Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.37 USD | -3.66% | +3.88% | +21.48% |
May. 08 | Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup | DJ |
May. 08 | R1 RCM Swings to Loss in Q1, Revenue Rises | MT |
Financials (USD)
Sales 2024 * | 2.63B | Sales 2025 * | 2.94B | Capitalization | 5.4B |
---|---|---|---|---|---|
Net income 2024 * | -2M | Net income 2025 * | 129M | EV / Sales 2024 * | 2.76 x |
Net Debt 2024 * | 1.84B | Net Debt 2025 * | 1.62B | EV / Sales 2025 * | 2.39 x |
P/E ratio 2024 * |
-148
x | P/E ratio 2025 * |
58.5
x | Employees | 29,650 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.94% |
Latest transcript on R1 RCM Inc.
1 day | +3.13% | ||
1 week | +3.88% | ||
Current month | +4.48% | ||
1 month | +0.55% | ||
3 months | +21.48% | ||
6 months | +18.45% | ||
Current year | +21.48% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-21 |
Director of Finance/CFO | - | 22-06-20 | |
John Sparby
PSD | President | 48 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 19-08-11 |
David Dill
BRD | Director/Board Member | 55 | 21-04-17 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 9 M€ | -.--% | - | |
0.03% | 0 M€ | +3.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 12.84 | +3.13% | 5 895 707 |
24-05-07 | 12.45 | -2.43% | 2,079,551 |
24-05-06 | 12.76 | +2.33% | 1,058,964 |
24-05-03 | 12.47 | +0.16% | 952,940 |
24-05-02 | 12.45 | +0.73% | 962,204 |
End-of-day quote Nasdaq, May 07, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.48% | 5.4B | |
+14.31% | 81.04B | |
-30.46% | 68.93B | |
+10.14% | 29.59B | |
+0.32% | 17.24B | |
-11.30% | 16.99B | |
-1.26% | 15.12B | |
+2.64% | 13.09B | |
+62.55% | 12B | |
+29.68% | 11.91B |
- Stock Market
- Equities
- RCM Stock